Send me a link:

*Text messaging rates may apply.

 Dow Down 1.10% Nasdaq Down 1.63%

Theravance Inc. (THRX)

-NasdaqGS
21.32 Down 0.63(2.87%) 10:59AM EDT - Nasdaq Real Time Price
Prev Close:21.95
Open:21.57
Bid:21.52 x 300
Ask:21.54 x 100
1y Target Est:28.83
Beta:0.63
Next Earnings Date: 6-Aug-14THRX Earnings announcement
Day's Range:21.32 - 21.90
52wk Range:20.23 - 34.53
Volume:161,392
Avg Vol (3m):1,333,620
Market Cap:2.40B
P/E (ttm):N/A
EPS (ttm):-1.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
THRXDown 2.87%2.40B
AZNDown 0.27%92.05B
CBSTDown 1.41%4.59B
PFEDown 0.80%185.14B

Key Statistics

Forward P/E (1 yr):718.00
P/S (ttm):690.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.19
Quarterly EPS Est (Jun-14) :-0.44
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback